A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole

Isavuconazole (ISCZ) is a novel antifungal agent that is expected to be effective against severe fungal diseases. A case of chronic pulmonary aspergillosis that was refractory to existing agents, such as micafungin, but was successfully treated by ISCZ, is presented.

Authors

Masafumi Seki (ORCID: https://orcid.org/0000-0001-5414-8148)

Institutions

Saitama Medical University (JP)

Publication Details

Journal: Global Journal of Medical Case Reports
Published: 2025-03-08
DOI: https://doi.org/10.31586/gjmcr.2025.6019
Primary Topic: Antifungal resistance and susceptibility
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole

Masafumi Seki

Mar 8, 2025

Global Journal of Medical Case Reports

Antifungal resistance and susceptibility

article

A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole

Masafumi Seki

March 8, 2025article en

Abstract

Global Journal of Medical Case ReportsVol. 5(1)

Saitama Medical University (JP)

Zero hunger

Openalex Percentile: Top 93%

Antifungal resistance and susceptibility

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Case of Severe Pulmonary Aspergillosis Successfully Treated by Isavuconazole — Masafumi Seki · Global Journal of Medical Case Reports (2025) | TGRS Research Map | TGRS